People channel feed

Build­ing on mo­men­tum from pos­i­tive di­a­betes da­ta, Zaf­gen scoops Bio­gen alum Priya Sing­hal as head of R&D

7 years ago

Ea­ger to think big­ger than Chi­na, As­cle­tis woos top Mer­ck ex­ec to run R&D

7 years ago

Parex­el re­cruits top FDA on­col­o­gy ex­pert Amy Mc­K­ee for new R&D ini­tia­tive

7 years ago
Pharma

Im­munomedics CEO Michael Pehl hits the ex­it on the heels of a CRL and ac­cu­sa­tions of a da­ta in­tegri­ty breach

7 years ago

Ra­maswamy's rare-dis­ease off­shoot En­zy­vant poach­es Alex­ion ex­ec Rachelle Jacques to re­place Alvin Shih at the helm

7 years ago

Ex-Cel­gene CEO Bob Hug­in makes a leap back in­to biotech, join­ing an em­bat­tled Al­ler­gan's board

7 years ago

David de Graaf has a new gig, a new idea and a new start­up — hunt­ing some new mon­ey

7 years ago
Startups

Vas Narasimhan earned a big pay hike when he moved to the CEO's suite at No­var­tis

7 years ago

As dig­i­tal med­i­cine ex­plodes in the zeit­geist of health­care, Sanofi fol­lows peers in ap­point­ing chief dig­i­tal of­fi­cer

7 years ago

Af­ter a short stint at In­ter­cept, Rachel McMinn makes the leap from biotech an­a­lyst to biotech CEO

7 years ago
Financing
Startups

David Schenkein gets his third act in biotech, join­ing Google's GV to co-lead life sci­ences group

7 years ago

As­traZeneca CEO So­ri­ot is over­see­ing a top ex­ec team over­haul in move to in­te­grate Med­Im­mune in a sweep­ing re­struc­tur­ing

7 years ago

Three se­nior Chimerix ex­ecs to hold the fort to re­place de­part­ing CEO Berrey

7 years ago

Shake­up at the top of FDA’s biosim­i­lars di­vi­sion as Leah Christl de­parts for Am­gen

7 years ago
Pharma

Pe­ter Dia­man­dis' right hand man Sergey Young wants to re­verse ag­ing via his $100M Longevi­ty Vi­sion Fund

7 years ago
Financing

'Most feared' ac­tivist in­vestor in Amer­i­ca has ze­roed in on Bris­tol-My­ers Squibb. Is he plan­ning to de­rail the $74B Cel­gene buy­out?

7 years ago
Deals

Buzzy an­ti-ag­ing biotech Cal­i­co re­cruits Am­gen vet for a top re­search post

7 years ago

Path to the top: What kind of ex­pe­ri­ence does it take to get tapped for the helm of a biotech?

7 years ago
In Focus

Hop­ing to brake a slow crash, Aduro's Stephen Isaacs hits the re­set but­ton, ax­ing staff in re­or­ga­ni­za­tion

7 years ago
R&D

Hit by tri­al set­back, Aslan slash­es staff and a study — hun­ker­ing down in wait for piv­otal da­ta

7 years ago

Dis­graced at Ver­tex, Ian Smith’s ca­reer im­plo­sion ends with swift ex­ile from biotech boards

7 years ago

Alexan­der Hardy tapped to head back to South San Fran­cis­co as the next CEO at Genen­tech

7 years ago

Ver­tex ousts long­time ex­ec Ian Smith over un­spec­i­fied code of con­duct vi­o­la­tions

7 years ago

Ed­i­tas founder Ka­trine Bosley abrupt­ly steps aside from the helm, just ahead of his­toric CRISPR move

7 years ago
First page Previous page 81828384858687 Next page Last page
A service from the Financial Times